Program

Tumor virology/Inflammation
Chair: U. Rapp (Würzburg), M. Dobbelstein (Göttingen)
Ch. von Kalle (Heidelberg): Cancer various vectors
T. Tüting (Bonn): Engaging anti-viral immune defence mechanisms for cancer therapy
A. zur Hausen (Freiburg): Merkel cell polyomavirus sequences are frequently detected in non-melanoma skin cancer of immunosuppressed patients

Short talks selected from abstracts
Chair: J. Becker (Würzburg), M. Rajewsky (Essen)
K. Milde-Langosch (Hamburg): Up-regulation of Fra-2 in breast cancer cells results in changes in cell adhesion and invasion
J. Hess (Heidelberg): AP-1 regulated genetic programs: From skin carcinogenesis to brain tumors

Break

Short talks selected from abstracts (continued)
Chair: J. Becker (Würzburg), M. Rajewsky (Essen)
S. Starke (Leipzig): TRAP1 expression levels influence MYCN-induced apoptosis in neuroblastoma cell lines and predict outcome in  neuroblastoma patients
S. Kaulfuß (Göttingen): Leupaxin acts as a mediator in prostate carcinoma progression via deregulation of p120 catenin expression
M. Augsten (Stockholm): CXCL14-expressing fibroblasts stimulate prostate cancer growth
D. Arlt (Heidelberg): The role of transmembrane protein Vmp1 in the formation of cell-cell contacts and its association with metastasis
V. Begay-Müller (Berlin): The translationally regulated LIP isoform of C/EBPb is oncogenic and functionally cooperates with p53
J. Heinzelmann (Jena): Identification of specific metastasis-associated miRNAs expression pattern in clear cell renal carcinoma

Poster prizes - Final Lecture
Chair: D.J. Jerry (Amherst)
D. Tuveson (Cambridge): Pancreatic Cancer Models and Medicine

Concluding remarks
R. Schäfer (Berlin)